NCT01130376 - Novel Interventions in HIV-1 Infection | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions

HIV-1 Infection

Interventions

BIOLOGICAL

GTU-MultiHIV B clade vaccine1mg

Dose given is 1mg/ml administered as 10 intradermal injections of 100 µl/injection distributed as 5 intradermal injections /left and right arm

DRUG

Interleukin-2

5 Million Units administered twice daily for 5 days by subcutaneous injection on days 7, 8, 9, 10, and 11 after first vaccination. .

DRUG

GM-CSF

150 ug administered subcutaneously once daily 4 hours from IL-2 injections

DRUG

Growth Hormone

4mg/day will be self administered by Subcutaneous injection for 5 days on days 14, 15, 16, 17 and 18 following first vaccination

Trial Locations (1)

St. Stephen's AIDS Trust, London